For clinical operations and development clinical feasibility teams, and patient representation leaders, as well as health economics and outcomes research (HEOR) teams, it is essential to understand the considerations when…

As the primary interface between healthcare providers (HCPs) and pharmaceutical companies, medical science liaisons (MSLs) have a unique opportunity to engage with HCPs in clinical discussions and bridge care gaps…

Over the past decade, the cost and time impact to bring drugs to market have been increasing. With the recent trends in healthcare (more inclusion for both patients as well…

As the healthcare industry shifts to value-based care, private payers and population health are taking the lead in determining patient care. For pharma and med tech companies, this shift…

H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies…

​Medical public awareness campaigns are designed to distribute important healthcare messages to large populations. With over seven billion people in the world, it is necessary to find ways to share…

When evaluating the feasibility of a clinical trial, it’s essential to consider what success means. This can mean defining criteria for your patient population, principal investigator (PI) qualifications, and…

Put simply – in 2022, clinical trial diversity, equity and inclusion (DEI) was top of mind for the pharma and biotech industries, across all phases of drug and device…

As we come out of the holidays , in the United States, some of the greatest minds in medicine and healthcare are gathered this week at the JP Morgan Healthcare…

When you google the term "clinical trial," the first thing that comes up is the National Library of Medicine site all about clinical research. It’s a great foray and…